It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mutations in myosin-VIIa (MYO7A) cause Usher syndrome type 1, characterized by combined deafness and blindness. MYO7A is proposed to function as a motor that tensions the hair cell mechanotransduction (MET) complex, but conclusive evidence is lacking. Here we report that multiple MYO7A isoforms are expressed in the mouse cochlea. In mice with a specific deletion of the canonical isoform (Myo7a-ΔC mouse), MYO7A is severely diminished in inner hair cells (IHCs), while expression in outer hair cells is affected tonotopically. IHCs of Myo7a-ΔC mice undergo normal development, but exhibit reduced resting open probability and slowed onset of MET currents, consistent with MYO7A’s proposed role in tensioning the tip link. Mature IHCs of Myo7a-ΔC mice degenerate over time, giving rise to progressive hearing loss. Taken together, our study reveals an unexpected isoform diversity of MYO7A expression in the cochlea and highlights MYO7A’s essential role in tensioning the hair cell MET complex.
How the ear achieves its remarkable sensitivity is still not fully understood. In this study, the authors demonstrate that the deafness protein myosin-VIIa and its isoforms are essential for tensioning the tip link, thereby sensitizing the auditory receptor cell’s mechanotransduction process.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 University of Virginia, Department of Neuroscience, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X); University of Virginia, Department of Biochemistry and Molecular Genetics, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X)
2 University of Colorado Anschutz Medical Campus, Department of Physiology and Biophysics, Aurora, USA (GRID:grid.430503.1) (ISNI:0000 0001 0703 675X)
3 University of Virginia, Department of Neuroscience, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X)
4 University of Virginia, Department of Mathematics, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X)
5 University of Virginia, Genetically Engineered Murine Model (GEMM) Core, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X)
6 National Institute of Health, National Institute for Deafness and Communications Disorders, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)